Short-chain fatty acids can improve lipid and glucose metabolism independently of the pig gut microbiota

Abstract

Background Previous studies have shown that exogenous short-chain fatty acids (SCFAs) introduction attenuated the body fat deposition in conventional mice and pigs. However, limited studies have evaluated the effects of exogenously introduced SCFAs on the lipid and glucose metabolism independently of the gut microbiota. This study was to investigate the effects of exogenous introduction of SCFAs on the lipid and glucose metabolism in a germ-free (GF) pig model. Methods Twelve hysterectomy-derived newborn pigs were reared in six sterile isolators. All pigs were hand-fed with sterile milk powder for 21 d, then the sterile feed was introduced to pigs for another 21 d. In the second 21-d period, six pigs were orally administrated with 25 mL/kg sterile saline per day and considered as the GF group, while the other six pigs were orally administrated with 25 mL/kg SCFAs mixture (acetic, propionic, and butyric acids, 45, 15, and 11 mmol/L, respectively) per day and regarded as FA group. Results Orally administrated with SCFAs tended to increase the adiponectin concentration in serum, enhance the CPT-1 activity in longissimus dorsi, and upregulate the ANGPTL4 mRNA expression level in colon (P < 0.10). Meanwhile, the mRNA abundances of ACC, FAS, and SREBP-1C in liver and CD36 in longissimus dorsi of the FA group were decreased (P < 0.05) compared with those in the GF group. Besides, the mRNA expression of PGC-1α in liver and LPL in longissimus dorsi tended to (P < 0.10) upregulate and downregulate respectively in the FA group. Moreover, oral administration of SCFAs tended to increase the protein level of GPR43 (P < 0.10) and decrease the protein level of ACC (P < 0.10) in liver. Also, oral administration of SCFAs upregulated the p-AMPK/AMPK ratio and the mRNA expressions of GLUT-2 and GYS2 in liver (P < 0.05). In addition, the metabolic pathway associated with the biosynthesis of unsaturated fatty acids was most significantly promoted (P < 0.05) by oral administration of SCFAs. Conclusions Exogenous introduction of SCFAs might attenuate the fat deposition and to some extent improve the glucose control in the pig model, which occurred independently of the gut microbiota.

Effects of oral glutamine supplementation on jejunal morphology, development, and amino acid profiles in male low birth weight suckling piglets

“…To overcome this impairment several nutritional strategies have been developed [ 1 , 19 ]. These include supplementations with colostrum [ 20 ] or bovine whey protein [ 21 ], nucleotides [ 22 ], short-chain fatty acids [ 23 ] and specific amino acids ( AA ) [ 24 ].…”

Association between gut microbiota and prediabetes in people living with HIV

“…It remains unclear how Christensenellaceae is involved in the hyperglycemic status. One possible mechanism is that Christensenellaceae can produce short-chain fatty acids, which are known to reduce the risk of diabetes by various mechanisms, for example, increased insulin sensitivity and suppression of appetite ( Lau and Vaziri, 2019 ; Waters and Ley, 2019 ; Zhou et al., 2021 ). Additionally, inflammation has been considered one of the causes of both type 1 and type 2 diabetes ( Tsalamandris et al., 2019 ).…”

Mechanisms Linking the Gut-Muscle Axis With Muscle Protein Metabolism and Anabolic Resistance: Implications for Older Adults at Risk of Sarcopenia

“…GPR41 and GRP43 are understood to stimulate GLP-1 and PYY secretion and increase insulin-mediated glucose uptake in skeletal muscle ( Canfora et al, 2015 ). In vivo studies have demonstrated improvements in insulin sensitivity, mitochondrial biogenesis and function, reduced adiposity, and an increase in type I muscle fiber composition following SCFA administration ( Fushimi et al, 2001 ; Gao et al, 2009 ; Hong et al, 2016 ; Zhou et al, 2021 ) that correspond with an increased myoglobin expression ( Yamashita et al, 2014 ; Maruta et al, 2016 ; Figure 2 ). Accordingly, germ-free mice supplemented with SCFA were shown to exhibit greater muscle (gastrocnemius) mass and strength compared to germ-free controls ( Lahiri et al, 2019 ).…”